Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
2.660
+0.030 (1.14%)
At close: Dec 23, 2024, 4:00 PM
2.670
+0.010 (0.38%)
After-hours: Dec 23, 2024, 6:31 PM EST

Pasithea Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
381939-
Market Cap Growth
-43.34%-58.92%-51.55%--
Enterprise Value
-6-11-2318-
Last Close Price
2.667.4012.8335.40-
PS Ratio
---2572.19-
PB Ratio
0.160.330.440.75-
P/TBV Ratio
0.620.540.570.75-
EV/Sales Ratio
---1206.82-
Debt / Equity Ratio
-0.000.01--
Asset Turnover
---0.00-
Quick Ratio
14.186.2217.62118.4236.90
Current Ratio
14.816.3418.15119.1737.55
Return on Equity (ROE)
-68.24%-47.07%-24.97%-8.41%-
Return on Assets (ROA)
-40.93%-28.02%-15.98%-10.52%-
Return on Capital (ROIC)
-43.32%-30.04%-16.67%-10.91%-
Earnings Yield
-468.28%-207.04%-74.25%-5.61%-
FCF Yield
-456.73%-174.58%-73.52%-8.25%-
Buyback Yield / Dilution
20.66%2.83%-142.65%-41.29%-
Total Shareholder Return
20.66%2.83%-142.65%-41.29%-
Source: S&P Capital IQ. Standard template. Financial Sources.